Positions

Selected Publications

Academic Article

Year Title Altmetric
2019 Hepatocellular carcinoma surveillance: An evidence-based approach 2019
2019 Emricasan Improves Liver Function in Patients With Cirrhosis and High Model for End-Stage Liver Disease Scores Compared With Placebo 2019
2018 Effect of Hepatitis C Treatment on Renal Function in Liver Transplant Patients. 2018
2018 Resolution of ascites and hepatic encephalopathy and absence of variceal bleeding in decompensated hepatitis C virus cirrhosis patients 2018
2018 Hepatitis C care cascade among persons born 1945-1965: 3 medical centers 2018
2018 Hepatitis C virus testing for case identification in persons born during 1945-1965: Results from three randomized controlled trials 2018
2018 Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma 2018
2017 Ledipasvir/sofosbuvir without ribavirin is effective in the treatment of recurrent hepatitis C virus infection post-liver transplant 2017
2017 The effect of transjugular intrahepatic portosystemic shunt on platelet counts in patients with liver cirrhosis 2017
2017 Short article: Alcohol and substance use, race, and insurance status predict nontreatment for hepatitis C virus in the era of direct acting antivirals: A retrospective study in a large urban tertiary center 2017
2017 Uptake of hepatitis C screening, characteristics of patients tested, and intervention costs in the BEST-C study 2017
2015 HIV Infection Status as a Predictor of Hepatitis C Virus RNA Testing in Primary Care 2015
2015 Hepatitis C virus antibody positivity and predictors among previously undiagnosed adult primary care outpatients: Cross-sectional analysis of a multisite retrospective cohort study 2015
2015 Hepatitis C Virus Testing Perspectives Among Primary Care Physicians in Four Large Primary Care Settings 2015
2014 Surveillance for hepatocellular carcinoma: Evidence, guidelines and utilization 2014
2013 Randomized study of asunaprevir plus pegylated interferon-α and ribavirin for previously untreated genotype 1 chronic hepatitis C 2013
2012 Equivalent survival following liver transplantation in patients with non-alcoholic steatohepatitis compared with patients with other liver diseases 2012
2012 The use of sirolimus should be restricted in liver transplantation 2012
2011 Noninvasive diagnosis of acute cellular rejection in liver transplant recipients: A proteomic signature validated by enzyme-linked immunosorbent assay 2011
2004 Resolution of Hereditary Hemorrhagic Telangiectasia and Anemia with Prolonged α-interferon Therapy for Chronic Hepatitis C 2004
2003 Hemoglobinuria with ribavirin treatment 2003

Chapter

Year Title Altmetric
2014 Variceal hemorrhage.  145-158. 2014

Research Overview

  • Hepatitis C Virus (HCV)
    Nonalcoholic Fatty Liver Disease (NASH)
    Liver transplantation
  • Principal Investigator On

  • Private Grant  awarded by SC LIVER RESEARCH CONSORTIUM 2017 - 2024
  • Private Grant  awarded by TOBIRA THERAPEUTICS 2018 - 2023
  • Private Grant  awarded by INTERCEPT PHARMACEUTICALS 2019 - 2023
  • Private Grant  awarded by CONATUS PHARMACEUTICALS, INC. 2017 - 2021
  • Private Grant  awarded by CONATUS PHARMACEUTICALS, INC. 2016 - 2020
  • Private Grant  awarded by CEPHEID 2015 - 2018
  • Private Grant  awarded by SC LIVER RESEARCH CONSORTIUM 2016 - 2018
  • Private Grant  awarded by SC LIVER RESEARCH CONSORTIUM 2016 - 2018
  • Private Grant  awarded by MERCK & COMPANY, INC. 2016
  • Private Grant  awarded by Gilead Sciences 2016
  • Private Grant  awarded by INTERCEPT PHARMACEUTICALS 2016
  • Private Grant  awarded by CONATUS PHARMACEUTICALS, INC. 2014 - 2016
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2012 - 2016
  • Birth-Cohort Evaluation to Advance Screening and Testing for Hepatitis C Study (BEST-C) (Phase 2)  awarded by CDC Foundation 2012 - 2016
  • Private Grant  awarded by VERTEX PHARMACEUTICALS, INC. 2012 - 2016
  • Private Grant  awarded by CONATUS PHARMACEUTICALS, INC. 2014
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2010 - 2014
  • Private Grant  awarded by KADMON PHARMACEUTICALS, LLC. 2013
  • Private Grant  awarded by Gilead Sciences 2013
  • Private Grant  awarded by SALIX PHARMACEUTICALS, INC. 2013
  • Private Grant  awarded by Genentech 2012
  • Private Grant  awarded by Gilead Sciences 2012
  • Hepatitis C Virus (HCV) Screening Practices and Prevalence in Primary Care Settings  awarded by RESEARCH TRIANGLE INSTITUTE 2010 - 2012
  • Private Grant  awarded by SC LIVER RESEARCH CONSORTIUM 2011
  • Investigator On

  • Private Grant  awarded by ARROWHEAD PHARMACEUTICALS INC. 2019 - 2023
  • Private Grant  awarded by Gilead Sciences 2015 - 2021
  • Acute Liver Failure Study Group 13C- Methacetin Breath Test for the Prediction of Acute Liver Failure  awarded by University of Texas Southwestern Medical Center at Dallas 2016 - 2020
  • Private Grant  awarded by MALLINCKRODT, INC. 2017 - 2020
  • Alabama Coalition for Testing, Interventions and Engagement in Hepatitis C Care (ACTIVE-Care)  awarded by GILEAD FOUNDATION 2017 - 2019
  • Alabama Coalition for Testing, Interventions, and Engagement in Hepatitis C Care (ACTIVE-Care)  awarded by GILEAD FOUNDATION 2015 - 2019
  • Private Grant  awarded by ALLERGAN SALES, LLC 2018 - 2019
  • Private Grant  awarded by INTERCEPT PHARMACEUTICALS 2016 - 2018
  • Private Grant  awarded by EISAI, INC. 2016 - 2017
  • Private Grant  awarded by OLYMPUS AMERICA 2016
  • A Phase 2A Study to Evaluate the Safety and Tolerability of OCR-002 (Ornithine Phenylacetate) in the Treatment of Patients with Acute Liver Failure/Severe Acute Liver Injury (STOP-ALF)  awarded by University of Texas Southwestern Medical Center at Dallas 2015 - 2016
  • Alabama Coalition for Testing, Interventions, and Engagement in Hepatitis C Care (ACTIVE-Care)  awarded by GILEAD FOUNDATION 2015 - 2016
  • Private Grant  awarded by SALIX PHARMACEUTICALS, INC. 2013 - 2015
  • Private Grant  awarded by SALIX PHARMACEUTICALS, INC. 2013 - 2015
  • Private Grant  awarded by OCERA THERAPEUTICS, INC. 2013 - 2014
  • Private Grant  awarded by SALIX PHARMACEUTICALS, INC. 2013 - 2014
  • Private Grant  awarded by VERTEX PHARMACEUTICALS, INC. 2012 - 2014
  • Private Grant  awarded by VITAL THERAPIES, INC 2012 - 2014
  • Private Grant  awarded by CLINUVEL PHARMACEUTICALS LTD 2012 - 2014
  • Private Grant  awarded by OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC 2012 - 2013
  • Education And Training

  • Case Western Reserve University, Internship 2002
  • Case Western Reserve University, Residency 2004
  • Mayo Clinic, Postdoctoral Fellowship 2009
  • Medical College of Wisconsin, Postdoctoral Fellowship 2008
  • Full Name

  • Omar Massoud